Noncontrast MRI out-of-pocket expenses vary quite a bit depending on geography and population.
Outpatient out-of-pocket costs for knee MRI vary considerably across the country, with lower prices in more populous areas, according to a study published in the Journal of the American College of Radiology.
Researchers from the Mayo Clinic in Rochester, MN, sought to determine the variability in pricing for noncontrast knee MRI, based on geographic location and population.
A total of 122 outpatient centers from 43 localities were included in the study. Nonhospital outpatient radiology centers were randomly chosen in each state’s highest-population locality, based on a list generated from the ACR MRI Accreditation Program database. The areas had to have at least two but no more than three centers for study inclusion. The data were further divided by population brackets: 50,000 to 500,000, 500,000 to 1 million, and more than 1 million.
The researchers, posing as a 21-year-old male college student who needed a noncontrast knee MRI to assess a knee injury sustained while playing football, contacted the centers by phone to determine the lowest, out-of-pocket, bundled cost (technical fee plus professional fee). The median (interquartile range) costs were calculated within each locality and region, including Midwest, Northeast, South, and West regions.
The results showed that costs for the examination ranged from $259 to $2,042 across all centers. For centers within a locality, the difference between the minimum and maximum costs ranged considerably among centers. For centers within a locality, the difference between the minimum and maximum costs among centers ranged from $1,592 to $0; median cost differences between localities ranged from $1,488 to $325.
Median cost geographically:
The researchers concluded that out-of-pocket expenses for outpatient knee MRIs varied considerably, both locally and nationally.
Diffusion-Weighted MRI and Neoadjuvant Chemotherapy for Rectal Cancer: What New Research Reveals
September 3rd 2024In a comparison of imaging assessments to gauge the effectiveness of neoadjuvant chemotherapy for rectal adenocarcinoma, researchers found the combination of diffusion-weighted imaging and MR tumor regression grading had a 90 percent area under the curve (AUC) and a negative predictive value (NPV) of 93 percent.
New Research Highlights Emerging MRI Contrast Agent for Bladder Imaging
August 21st 2024A new MRI contrast agent may provide a viable non-invasive alternative for the detection of interstitial cystitis, according to preliminary research presented at the 5th International Consultation on Interstitial Cystitis Japan (ICICJ) in Kyoto, Japan.
MRI Study Offers Insights on Traumatic Brain Injury and Cerebral Microbleeds
August 19th 2024Detecting cerebral microbleed (CMB) in one of six healthy adults in a new study, researchers also found that CMB was the only MRI marker of small vessel disease (SVD) to be significantly associated with traumatic brain injury (TBI).